Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Microbio CoROCO:4128 -1.55%56 EBITDA Margin % is -6.19% as of Dec. 2025. GuruFocus rates ROCO:4128 with a GF Score™ of 56/100 and a GF Value™ of NT$45.77 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 1,959 Consumer Packaged Goods companies, Microbio Co ranks worse than 94.54% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Microbio Co's EBITDA for the
three
months ended in Dec. 2025 was NT$-32 Mil. Microbio Co's Revenue for the
three
months ended in Dec. 2025 was NT$511 Mil. Therefore, Microbio Co's EBITDA margin for the quarter that ended in Dec. 2025 was -6.19%.
Microbio Co (ROCO:4128) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Microbio Co EBITDA Margin % Related Terms
Microbio Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Microbio Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Microbio Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Microbio Co EBITDA Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Microbio Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Microbio Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Microbio Co (ROCO:4128) has a EBITDA Margin % of -6.19% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Microbio Co and its competitors. According to the industry distribution chart, Microbio Co ranks #1852 out of 1959 companies in the Consumer Packaged Goods industry, placing it in the top 94.5%.
Is Microbio Co's EBITDA Margin % too high?
Microbio Co's current EBITDA Margin % is -6.19%. Based on the distribution chart, Microbio Co ranks #1852 out of 1959 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Microbio Co has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Microbio Co's EBITDA Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Microbio Co ranks #1852 out of 1959 companies for EBITDA Margin %. This places Microbio Co in the lower half of its industry. The industry median EBITDA Margin % is 8.99. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 8.99, based on 1,959 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Microbio Co and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 8.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Microbio Co's current EBITDA Margin % is -6.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbio Co stock overvalued right now?
Based on GuruFocus' analysis, Microbio Co (ROCO:4128) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$45.77, compared to a current price of NT$15.85 — trading 65.4% below its estimated fair value. The current EBITDA Margin % is -6.19%. Microbio Co's overall GF Score™ is 56/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Microbio Co (ROCO:4128), the current EBITDA Margin % is -6.19% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Microbio Co (ROCO:4128) Overvalued in 2026?
Based on GuruFocus' analysis, Microbio Co stock appears to be undervalued.
The current stock price of NT$15.85 is trading 65.4% below its estimated GF Value™ of NT$45.77.
GuruFocus considers Microbio Co to be Significantly Undervalued.
Key valuation signals for ROCO:4128:
EBITDA Margin %: -6.19%
GF Value™: NT$45.77 vs. price of NT$15.85 (65.4% below fair value)
No single metric tells the full story. See the ROCO:4128 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Microbio Co Ltd is engaged in the research and development, manufacturing, and trading of biotech drugs and dietary supplements. Its drug portfolio includes MS-20, a mixture of soybean fermentation metabolites, which improves fatigue and loss of appetite in cancer patients undergoing chemotherapy. In addition, the company also offers Lee Herb series of herbal essence drinks, Tien Chun Bao oral solutions, Herbiron oral solutions for iron deficiency, and other pharmaceutical and organic products. The company generates revenue from biotech drug research and development and the sale of dietary supplements. The majority of its revenue is generated from the sale of its dietary supplements.
56GF Score
Get the complete analysis for ROCO:4128
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4128 has been successfully added to your 
